Andrea D. Chapman

527 total citations
20 papers, 361 citations indexed

About

Andrea D. Chapman is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Andrea D. Chapman has authored 20 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Andrea D. Chapman's work include Sarcoma Diagnosis and Treatment (4 papers), Medical Imaging and Pathology Studies (4 papers) and RNA modifications and cancer (3 papers). Andrea D. Chapman is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Medical Imaging and Pathology Studies (4 papers) and RNA modifications and cancer (3 papers). Andrea D. Chapman collaborates with scholars based in United Kingdom, United States and India. Andrea D. Chapman's co-authors include Keith M. Kerr, George King, Robert R. Jeffrey, Margaret M. Kennedy, M. Nicolson, Kim W Ah-See, Malcolm Loudon, Stuart C. Pritchard, V Shanmugam and Patrick H. Rooney and has published in prestigious journals such as Cancer, British Journal of Cancer and The Journal of Pathology.

In The Last Decade

Andrea D. Chapman

19 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea D. Chapman United Kingdom 10 174 162 81 79 56 20 361
Nilesh Mehta United States 5 100 0.6× 319 2.0× 82 1.0× 51 0.6× 55 1.0× 6 389
Masayuki Urabe Japan 10 136 0.8× 136 0.8× 91 1.1× 38 0.5× 178 3.2× 35 357
Go Makimoto Japan 10 193 1.1× 147 0.9× 81 1.0× 26 0.3× 34 0.6× 60 298
Masatoshi Kanayama Japan 11 158 0.9× 245 1.5× 35 0.4× 69 0.9× 48 0.9× 49 351
Nayneeta Deshmukh United Kingdom 8 133 0.8× 93 0.6× 94 1.2× 57 0.7× 129 2.3× 13 319
Naikang Zhou China 10 250 1.4× 141 0.9× 84 1.0× 16 0.2× 85 1.5× 40 401
Takuho Okamura Japan 10 70 0.4× 207 1.3× 42 0.5× 72 0.9× 30 0.5× 30 331
Moises J. Velez United States 7 114 0.7× 234 1.4× 85 1.0× 40 0.5× 39 0.7× 14 316
Yuji Hirami Japan 10 162 0.9× 222 1.4× 96 1.2× 145 1.8× 32 0.6× 21 405

Countries citing papers authored by Andrea D. Chapman

Since Specialization
Citations

This map shows the geographic impact of Andrea D. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea D. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea D. Chapman more than expected).

Fields of papers citing papers by Andrea D. Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea D. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea D. Chapman. The network helps show where Andrea D. Chapman may publish in the future.

Co-authorship network of co-authors of Andrea D. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea D. Chapman. A scholar is included among the top collaborators of Andrea D. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea D. Chapman. Andrea D. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molerón, R., et al.. (2021). Simultaneous double laryngeal tumours: a diagnostic and therapeutic challenge. BMJ Case Reports. 14(2). e239797–e239797. 2 indexed citations
2.
Chapman, Andrea D., et al.. (2021). Morphological assessment of collagen IV expression in oral cancer and oral potentially malignant disorders: a pilot study. Banach Center Publications. 124. 111–122. 1 indexed citations
3.
Shakeel, Muhammad, et al.. (2011). Amyloidosis of the nasopharynx: an unexpected cause of unilateral middle ear effusion.. PubMed. 21(11). 706–7.
4.
Sawhney, Simon, Andrea D. Chapman, J. Aidan Carney, Lesley Gomersall, & Owen Dempsey. (2009). Incomplete Carney triad--a review of two cases. QJM. 102(9). 649–653. 9 indexed citations
5.
Kerr, Keith M., Graham Devereux, Andrea D. Chapman, et al.. (2007). D4-05: Is survival after surgical resection of lung cancer influenced by the presence of atypical adenomatous hyperplasia (AAH)?. Journal of Thoracic Oncology. 2(8). S401–S402. 2 indexed citations
6.
Shanmugam, V, Angus Watson, Andrea D. Chapman, N R Binnie, & Malcolm Loudon. (2005). Pathological audit of stapled haemorhoidopexy. Colorectal Disease. 7(2). 172–175. 19 indexed citations
7.
Ah-See, Kim W, et al.. (2005). Interdigitating dendritic cell sarcoma of the parotid gland. The Journal of Laryngology & Otology. 120(3). 244–246. 17 indexed citations
8.
Kerr, Keith M., Graeme I. Murray, Nicky Fyfe, et al.. (2004). Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma. The Journal of Pathology. 203(2). 638–644. 26 indexed citations
9.
Ah-See, Kim W, et al.. (2004). Malignant Peripheral Nerve Sheath Tumor of the Paranasal Sinuses. Ear Nose & Throat Journal. 83(10). 699–701. 10 indexed citations
10.
Stephens, Nathan, et al.. (2003). Extra-Abdominal Fibromatosis: A Case Report. Ear Nose & Throat Journal. 82(4). 322–325. 1 indexed citations
11.
Kerr, Keith M., Nicky Fyfe, Andrea D. Chapman, Nicholas Coleman, & M. Nicolson. (2003). O-39 Cell cycle marker MCM2 in peripheral lung adenocarcinoma and its precursors. Lung Cancer. 41. S15–S15. 3 indexed citations
12.
Kerr, Keith M., et al.. (2003). O-41 Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in lung adenocarcinoma and its precursors. Lung Cancer. 41. S15–S15. 1 indexed citations
13.
Chapman, Andrea D., Stuart C. Pritchard, Patrick H. Rooney, et al.. (2001). Primary pulmonary osteosarcoma. Cancer. 91(4). 779–784. 17 indexed citations
14.
Chapman, Andrea D., Stuart C. Pritchard, Patrick H. Rooney, et al.. (2001). Primary pulmonary osteosarcoma: case report and molecular analysis.. PubMed. 91(4). 779–84. 20 indexed citations
15.
Chapman, Andrea D. & Keith M. Kerr. (2000). The association between atypical adenomatous hyperplasia and primary lung cancer. British Journal of Cancer. 83(5). 632–636. 86 indexed citations
16.
Kerr, Keith M., et al.. (2000). Expression of CD44v6 but not E-cadherin or ?-catenin influences prognosis in primary pulmonary adenocarcinoma. The Journal of Pathology. 192(4). 427–432. 29 indexed citations
17.
Kerr, Keith M., et al.. (2000). Expression of CD44v6 but not E‐cadherin or β‐catenin influences prognosis in primary pulmonary adenocarcinoma. The Journal of Pathology. 192(4). 427–432. 1 indexed citations
18.
Kerr, Keith M., et al.. (2000). Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer. 27(1). 27–35. 107 indexed citations
19.
20.
Chapman, Andrea D., et al.. (1999). Right Heart Failure as the Dominant Clinical Picture in a Case of Primary Amyloidosis Affecting the Pulmonary Vasculature. Scottish Medical Journal. 44(4). 116–117. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026